|
[1]
|
Tao, H., Mo, Y., Liu, W. and Wang, H. (2023) A Review on Gout: Looking Back and Looking Ahead. International Immunopharmacology, 117, Article 109977. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, M., Nie, Q., Xia, Q. and Jiang, Z. (2025) Assessing Cross-National Inequalities and Predictive Trends in Gout Burden: A Global Perspective (1990-2021). Frontiers in Medicine, 12, Article 1527716. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Liu, R., Han, C., Wu, D., Xia, X., Gu, J., Guan, H., et al. (2015) Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. BioMed Research International, 2015, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Stamp, L.K. and Dalbeth, N. (2022) Critical Appraisal of Serum Urate Targets in the Management of Gout. Nature Reviews Rheumatology, 18, 603-609. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Dehlin, M., Jacobsson, L. and Roddy, E. (2020) Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nature Reviews Rheumatology, 16, 380-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Michie, S., van Stralen, M.M. and West, R. (2011) The Behaviour Change Wheel: A New Method for Characterising and Designing Behaviour Change Interventions. Implementation Science, 6, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Eaton, C., Comer, M., Pruette, C., Psoter, K. and Riekert, K. (2020) Text Messaging Adherence Intervention for Adolescents and Young Adults with Chronic Kidney Disease: Pilot Randomized Controlled Trial and Stakeholder Interviews. Journal of Medical Internet Research, 22, e19861. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Rockliffe, L., Peters, S., Smith, D.M., Heal, C. and Heazell, A.E.P. (2022) Investigating the Utility of the COM-B and TM Model to Explain Changes in Eating Behaviour during Pregnancy: A Longitudinal Cohort Study. British Journal of Health Psychology, 27, 1077-1099. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
谢传桃, 顾艳荭, 李玉梅, 等. 基于com-b模型的老年慢性心力衰竭病人服药依从性影响因素[J]. 护理研究, 2024, 38(2): 246-251.
|
|
[10]
|
Ho, G.H., Pillinger, M.H. and Toprover, M. (2020) Adherence to Gout Guidelines: Where Do We Stand? Current Opinion in Rheumatology, 33, 128-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kołtuniuk, A. and Chojdak-Łukasiewicz, J. (2023) Beliefs about Medicines and the Level of Intentional Non-Adherence to Treatment among Patients with Multiple Sclerosis Treated with First-Line Drugs. Journal of Clinical Medicine, 13, Article 182. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Laughlin, A.I., Cao, Q., Bryson, R., Haughey, V., Abdul-Salaam, R., Gonzenbach, V., et al. (2023) Detection of Medication Taking Using a Wrist-Worn Commercially Available Wearable Device. JCO Clinical Cancer Informatics, 7, e2200107. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Meglio, M., Manubens, R.T., Fernández-Álvarez, J., Marasas, S., García, F., Gómez, B., et al. (2024) Implementation of an Ecological Momentary Assessment (EMA) in Naturalistic Psychotherapy Settings: Qualitative Insights from Patients, Therapists, and Supervisors Perspectives. Administration and Policy in Mental Health and Mental Health Services Research, 51, 439-454. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Spragg, J.C.J., Michael, T.J.F., Aslani, P., Coleshill, M.J., Chan, J.S., Day, R.O., et al. (2023) Optimizing Adherence to Allopurinol for Gout: Patients’ Perspectives. British Journal of Clinical Pharmacology, 89, 1978-1991. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Sigurdardottir, V., Svärd, A., Jacobsson, L. and Dehlin, M. (2022) Gout in Dalarna, Sweden—A Population-Based Study of Gout Occurrence and Compliance to Treatment Guidelines. Scandinavian Journal of Rheumatology, 52, 498-505. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Russell, M.D., Massey, J., Roddy, E., MacKenna, B., Bacon, S., Goldacre, B., et al. (2023) Gout Incidence and Management during the COVID-19 Pandemic in England, UK: A Nationwide Observational Study Using OpenSAFELY. The Lancet Rheumatology, 5, e622-e632. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
蒋海艳. 痛风患者降尿酸治疗服药依从性调查及影响因素分析[D]: [硕士学位论文]. 成都: 成都医学院, 2021.
|
|
[18]
|
曹双燕, 刘回芬, 邵战琴, 等. 痛风患者服药依从性和健康赋权水平及其影响因素分析[J]. 广东医学, 2024, 45(1): 45-49.
|
|
[19]
|
Briesacher, B.A., Andrade, S.E., Fouayzi, H. and Chan, K.A. (2008) Comparison of Drug Adherence Rates among Patients with Seven Different Medical Conditions. Pharmacotherapy, 28, 437-443. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Gudeta, D.B., Leta, K., Alemu, B. and Kandula, U.R. (2023) Medication Adherence and Associated Factors among Psychiatry Patients at Asella Referral and Teaching Hospital in Oromia, Ethiopia: Institution Based Cross Sectional Study. PLOS ONE, 18, e0283829. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Uhlig, T., Karoliussen, L.F., Sexton, J., Provan, S.A., Haavardsholm, E.A., Dalbeth, N., et al. (2024) Non-Adherence to Urate Lowering Therapy in Gout after 5 Years Is Related to Poor Outcomes: Results from the NOR-Gout Study. Rheumatology, 64, 1799-1806. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hu, S., He, S., Zhang, J., Ma, W., Geng, H., Zhan, Z., et al. (2024) Association between Patient Adherence and Treat-To-Target in Gout: A Cross-Sectional Study. Medicine, 103, e37228. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zeng, X., Liu, Y., Fan, Y., Wu, D., Meng, Y. and Qin, M. (2023) Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of Medicinal Chemistry, 66, 14474-14493. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yin, R., Lu, J., Xu, Z., Yan, Q., Wang, M. and Xu, R. (2023) Urate-Lowering Therapy Adherence and the Association with Medication Beliefs, Self-Efficacy, Depression, Anxiety, and COVID-19 Pandemic-Related Concern in Chinese Gout Patients: A Cross-Sectional Study. Psychology, Health & Medicine, 28, 1698-1708. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Ofanoa, S., Ofanoa, M., Tu’akoi, S., Lutui, H., Heather, M. and Goodyear-Smith, F. (2025) Pacific Community’s Perceptions on How to Improve Uptake of Urate-Lowering Therapy for Pacific Gout Patients. International Journal for Equity in Health, 24, Article No. 91. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Görgülü, M.B., Kardaş, R.C., Koç Şeramet, D., Mercan, R., Tezcan, M.E., Küçük, H., et al. (2025) Evaluation of Treatment Compliance in Gout Patients: A Patient-Centered Study. Turkish Journal of Medical Sciences, 55, 413-422. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Roman, Y.M. (2022) Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices. Nutrients, 14, Article 3590. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Veenstra, F., Verhoef, L.M., Nieboer, L., et al. (2020) Thu0448 No Difference in Gout Flares after Initiation of Urate Lowering Therapy between Once or Twice Daily 0.5 mg Colchicine Prophylaxis. Annals of the Rheumatic Diseases, 79, Article 461.
|
|
[29]
|
Hu, S., Terkeltaub, R., Sun, M., Ji, X., Li, Z., Ran, Z., et al. (2022) Palpable Tophi and More Comorbidities Associated with Adherence to Urate-Lowering Medical Therapy in a Chinese Gout Cohort. Joint Bone Spine, 89, Article 105435. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Peeters, I.R., Veenstra, F., Wanten, S.A.C., Vriezekolk, J.E., van den Ende, C.H., den Broeder, A.A., et al. (2024) Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy during Remission: A Mixed-Methods Study. Arthritis Care & Research, 76, 1574-1583. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Lee, S. and So, M.W. (2016) Adherence with Urate-Lowering Therapies among Male Patients with Gout in a Routine Clinical Setting. Modern Rheumatology, 26, 950-955. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Horne, C.E., Abel, W.M. and Crane, P.B. (2023) Fatigue, Stress, and Blood Pressure Medication Adherence by Race after Myocardial Infarction. The Journal for Nurse Practitioners, 19, Article 104757. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Day, R.O., Frensham, L.J., Nguyen, A.D., Baysari, M.T., Aung, E., Lau, A.Y.S., et al. (2017) Effectiveness of an Electronic Patient-Centred Self-Management Tool for Gout Sufferers: A Cluster Randomised Controlled Trial Protocol. BMJ Open, 7, e017281. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
吴柳英, 黄丽, 谌佳, 等. 移动终端延续护理对急性痛风性关节炎患者的影响[J]. 齐鲁护理杂志, 2023, 29(24): 152-154.
|
|
[35]
|
刘伟, 兰由玉, 陶蓓. 泸州地区高尿酸血症和痛风患者健康教育及管理平台的构建及应用[J]. 临床医学研究与实践, 2024, 9(23): 29-33.
|
|
[36]
|
Michael, T.J.F., Chan, J.S., Hughes, S., Wright, D.F.B., Coleshill, M.J., Hughes, D.A., et al. (2024) The Experiences and Perspectives of People with Gout on Urate Self-Monitoring. Health Expectations, 27, e14071. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Emad, Y., Dalbeth, N., Weinman, J., Chalder, T. and Petrie, K.J. (2023) Can Smartphone Notifications Help with Gout Management? The Journal of Rheumatology, 51, 189-196. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Fuller, A., Jenkins, W., Doherty, M. and Abhishek, A. (2019) Nurse-Led Care Is Preferred over GP-Led Care of Gout and Improves Gout Outcomes: Results of Nottingham Gout Treatment Trial Follow-Up Study. Rheumatology, 59, 575-579. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
赖迎秋, 肖兰杰, 向望. 护士主导的概念验证健康教育在痛风性关节炎患者中的应用[J]. 护理学杂志, 2021, 36(10): 85-88.
|
|
[40]
|
Singh, J.A., Richards, J.S., Chang, E., Toupin-April, K. and Barton, J.L. (2020) Shared Decision-Making in Gout Treatment: A National Study of Rheumatology Provider Opinion and Practice. Clinical Rheumatology, 40, 693-700. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Kelly, A., Tymms, K., de Wit, M., Bartlett, S.J., Cross, M., Dawson, T., et al. (2020) Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group Technique. Arthritis Care & Research, 72, 1410-1419. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
王静. 社区医生综合干预在痛风患者中的应用效果分析[J]. 中国社区医师, 2025, 41(7): 147-149.
|
|
[43]
|
Mikuls, T.R., Cheetham, T.C., Levy, G.D., et al. (2019) A Pharmacist-Led Intervention to Improve Gout Medication Adherence and Outcomes with Urate Lowering Therapy: A Site Randomized Trial. The American Journal of Medicine, 132, 354-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
张娟娟, 朱美红, 刘娜, 等. 家庭医生签约制度下临床药师对痛风患者的管理实践[J]. 中国药业, 2025, 34(1): 21-24.
|
|
[45]
|
Hill-McManus, D., Marshall, S., Soto, E., Lane, S. and Hughes, D. (2018) Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout. Value in Health, 21, 1373-1381. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
张志明, 黄青青, 齐张, 等. 痛风急性期起始降尿酸治疗对临床疗效及用药依从性的影响[J]. 风湿病与关节炎, 2019, 8(4): 24-27.
|
|
[47]
|
李莹, 刘婷, 姚新宇, 等. 居家男性痛风患者服药依从性及影响因素分析[J]. 护理学杂志, 2019, 34(17): 79-82+93.
|
|
[48]
|
Jackson, L.E., Saag, K.G., Chiriboga, G., Lemon, S.C., Allison, J.J., Mudano, A., et al. (2023) A Multi-Step Approach to Develop a “Storytelling” Intervention to Improve Patient Gout Knowledge and Improve Outpatient Follow-Up. Contemporary Clinical Trials Communications, 33, Article 101149. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Fontanet, C.P., Choudhry, N.K., Wood, W., Robertson, T., Haff, N., Oran, R., et al. (2021) Randomised Controlled Trial Targeting Habit Formation to Improve Medication Adherence to Daily Oral Medications in Patients with Gout. BMJ Open, 11, e055930. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
黄高婧. 基于福格行为模型的中医健康管理系统设计研究——以痛风及高尿酸血症患者为例[D]: [硕士学位论文]. 无锡: 江南大学, 2025.
|
|
[51]
|
林晓燕, 张玉珍, 陈娟. 慢病授权赋能教育联合分阶段健康管理在痛风性关节炎患者中的应用[J]. 中外医学研究, 2025, 23(10): 94-97.
|